Raymond James Financial Inc Hutchmed (China) LTD Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 614 shares of HCM stock, worth $9,879. This represents 0.0% of its overall portfolio holdings.
Number of Shares
614Holding current value
$9,879% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HCM
# of Institutions
62Shares Held
6.07MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$41.5 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$14.9 Million0.02% of portfolio
-
State Street Corp Boston, MA329KShares$5.29 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$5.08 Million0.11% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.65 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.78B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...